Genspark's recent $275 million Series B session, backed by key investors, aims to redefine productivity for knowledge workers through its new AI Workspace platform.

ONERWAY, backed by Lanchi Ventures, successfully raised $10 million in Series A+ funding to enhance its global payments infrastructure, signaling strong investor support.

Allink Biotherapeutics has successfully raised $42 million in Series A funding to further develop bispecific antibodies and ADCs in global markets.

Allink Biotherapeutics has successfully raised $42 million in Series A funding, marking a significant step in advancing its bispecific antibody and ADC programs.